retatrutide clinical trial results safety Lilly's triple agonist achieves 16.8% weight loss in phase 3 Lilly orforglipron oral GLP-1 phase

Intranasal exendin-4 administration without CPP contributed to learning in the SAMP8 mouse model and coadministration of L-penetratin and insulin improved cognitive function by facilitating the brain delivery of exendin-4 and insulin signaling activation in the brain (Kamei et al., 2018)

Semaglutide GLP-1 is most effective when combined with healthy lifestyle changes, including a balanced diet and regular physical activity

Lipoic acid and its reduced form, dihydrolipoic acid (DHLA), neutralize the free radicals in both lipid and aqueous domains and as such has been called a universal antioxidant. Superoxide dismutase Superoxide dismutases (SODs) are a class of enzymes that catalyse the breakdown of the superoxide anion into oxygen and hydrogen peroxide

But given the recent findings in human studies, semaglutide may be helpful for anyone at risk for Alzheimers disease

Realistically expect 1 to 3% of body weight lost in the first month

However, although trials have shown the drugs to be safe and effective, they are not without their side-effects most commonly nausea, vomiting, diarrhoea, constipation and decreased appetite